Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: ...

In the assessment of 12-month price targets, analysts unveil insights for Voyager Therapeutics, presenting an average target ...

For Muhammad Salman Hameed, a Pakistani researcher, his six years of experience in China have been highly rewarding. He has ...

Richmond is pleased to announce the promotions of Dr Matej Goricar and Dr Amir Majid to senior roles within the Medical Directorate as Associate Medical Directors. These advancements reflect their ...

Chronic diseases like type 2 diabetes and inflammatory disorders have a huge impact on humanity. They are a leading cause of ...

Chronic diseases like type 2 diabetes and inflammatory disorders have a huge impact on humanity. They are a leading cause of disease burden and deaths around the globe, are physically and economically ...

Researchers hope findings will lead to new class of drugs for many different diseases for which proteolethargy is a common ...

Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.

Oct. 28, 2024 — Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing function. These preclinical ...

Genes make up the blueprints and outline the process of building every living organism. To ensure that the right genes are ...

Arrowhead Pharmaceuticals (ARWR) has secured a new partnership with Sarepta Therapeutics (SRPT). Under the terms of the deal, ...